相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
Mette Simone Aae Madsen et al.
SCIENTIFIC REPORTS (2019)
Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism
Sheng-Hua Yang et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins
Yukiko Hasegawa et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways
Gunaj Rakipovski et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver
Seonghwan Hwang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance
Rituraj Khound et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice
Qing-hua Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
Jennifer Taher et al.
MOLECULAR METABOLISM (2014)
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE(-/-) Mice
Naim Panjwani et al.
ENDOCRINOLOGY (2013)
Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr-/- mice versus hamsters
Christophe Gardes et al.
JOURNAL OF LIPID RESEARCH (2013)
Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice
Jinmi Lee et al.
PLOS ONE (2012)
GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
Edwin T. Parlevliet et al.
PLOS ONE (2012)
Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
Eric A. Schwartz et al.
ATHEROSCLEROSIS (2010)
Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database
Edward S. Horton et al.
DIABETES CARE (2010)
Transcriptional Regulation of HMG-CoA Synthase and HMG-CoA Reductase Genes by Human ACBP
Christina Vock et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
David C. Klonoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
Xiaomei Qin et al.
HEPATOLOGY (2008)
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
Diana Jung et al.
JOURNAL OF LIPID RESEARCH (2007)
Regulation of hepatic Insig-2 by the farnesoid X receptor
Melissa L. Hubbert et al.
MOLECULAR ENDOCRINOLOGY (2007)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones
V Ionut et al.
DIABETOLOGIA (2005)
Rate of gastric emptying influences dietary cholesterol absorption efficiency in selected inbred strains of mice
RJ Kirby et al.
JOURNAL OF LIPID RESEARCH (2004)
The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion
PE MacDonald et al.
DIABETES (2002)
分享论文
